GSK (GSK)

Sector:

Pharma and Biotech

Index:

FTSE 100

1,653.00p
   
  • Change Today:
      12.50p
  • 52 Week High: 1,711.20
  • 52 Week Low: 1,316.00
  • Currency: UK Pounds
  • Shares Issued: 4,144.88m
  • Volume: 3,273,134
  • Market Cap: £68,515m
  • RiskGrade: 129

Fundamentals - based on IFRS

  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Income Statement 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Continuing Operations          
Revenue 7,178.00 6,929.00 5,838.00 7,624.00 7,809.00
Operating Profit/(Loss) 2,141.00 1,081.00 1,275.00 2,850.00 1,484.00
Profit Before Tax 1,987.00 896.00 1,070.00 2,641.00 1,264.00
Profit After Tax 1,745.00 746.00 1,271.00 2,440.00 1,050.00
Discontinued Operations          
Profit After Tax n/a 229.00 267.00 n/a n/a
PROFIT FOR THE PERIOD 1,745.00 975.00 1,538.00 2,440.00 1,050.00
           
Continuing EPS          
Earnings per Share - Basic 40.10p 21.88p 30.30p 45.50p 19.50p
Earnings per Share - Diluted 39.70p 21.75p 30.10p 45.00p 19.30p
Earnings per Share - Adjusted 38.80p 43.38p 28.20p 19.20p 30.50p
Continuing and Discontinued EPS          
Earnings per Share - Basic 40.10p 26.00p 34.80p 45.50p 19.50p
Earnings per Share - Diluted 39.70p 25.75p 34.50p 45.00p 19.30p
Earnings per Share - Adjusted 38.80p 43.38p 28.20p 19.20p 30.50p
Dividend per Share 14.00p 20.31p 23.75p 19.00p 19.00p
  £ (Millions) £ (Millions) £ (Millions) £ (Millions) £ (Millions)
Balance Sheet 30-Jun-23 30-Jun-22 30-Jun-21 30-Jun-20 30-Jun-19
Total Non-Current Assets 40,113.00 34,857.00 59,445.00 61,662.00 45,404.00
Net Current Assets cn/a cn/a cn/a cn/a cn/a
Total Assets 59,461.00 89,045.00 77,011.00 84,640.00 63,632.00
Total Liabilities 47,302.00 66,405.00 55,433.00 64,503.00 60,665.00
Net Assets 12,159.00 22,640.00 21,578.00 20,137.00 2,967.00
           
Shareholders Funds 12,691.00 16,374.00 15,377.00 13,593.00 3,614.00
Minority Interests/Other Equity (532.00) 6,266.00 6,201.00 6,544.00 (647.00)
Total Equity 12,159.00 22,640.00 21,578.00 20,137.00 2,967.00

Key

* GAAP

a. Includes discontinued activities

b. Including assets due in more than one year

c. Not disclosed under IFRS

d. Total fixed assets

e. Includes borrowings

f. Included in cash flow from operating activities under IFRS

g. Included in net cash from investing activities under IFRS

h. Pre-tax

i. Capital expenditure

j. Based on operating cash flow before tax

k. Issue of ordinary shares

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: Forecast figures based on normalised accounts.

 

Top of Page